MENU
+Compare
EKSO
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$0.55
Change
-$0.01 (-1.79%)
Capitalization
24.35M

EKSO Ekso Bionics Holdings Forecast, Technical & Fundamental Analysis

a robotic exoskeleton company, which designs and develops exoskeletons and wearable robots

EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EKSO with price predictions
Feb 21, 2025

EKSO saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for EKSO moved out of overbought territory on February 21, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 44 similar instances where the indicator exited the overbought zone. In of the 44 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for EKSO crossed bearishly below the 50-day moving average on January 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EKSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EKSO entered a downward trend on February 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 14, 2025. You may want to consider a long position or call options on EKSO as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EKSO just turned positive on February 13, 2025. Looking at past instances where EKSO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EKSO advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

EKSO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.875) is normal, around the industry mean (23.448). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.001) is also within normal values, averaging (41.230).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EKSO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EKSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EKSO is expected to report earnings to fall 15.00% to -8 cents per share on February 27

Ekso Bionics Holdings EKSO Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.13
Q1'24
Missed
by $0.13
Q4'23
Missed
by $0.11
The last earnings report on October 28 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 96.08K shares outstanding, the current market capitalization sits at 24.35M.
A.I. Advisor
published General Information

General Information

a robotic exoskeleton company, which designs and develops exoskeletons and wearable robots

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glacier Point
Phone
+1 510 984-1761
Employees
73
Web
https://www.eksobionics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REX41.27-0.42
-1.01%
REX American Resources Corp
SATS29.57-0.60
-1.99%
EchoStar Corp
TRGP200.36-4.34
-2.12%
Targa Resources Corp
GTE5.67-0.22
-3.74%
Gran Tierra Energy
HOFV1.09-0.06
-5.22%
Hall of Fame Resort & Entertainment Company

EKSO and Stocks

Correlation & Price change

A.I.dvisor tells us that EKSO and MBOT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
-2.18%
MBOT - EKSO
26%
Poorly correlated
-7.02%
ATEC - EKSO
25%
Poorly correlated
-0.47%
GENE - EKSO
25%
Poorly correlated
N/A
ICLR - EKSO
24%
Poorly correlated
-0.22%
MASS - EKSO
24%
Poorly correlated
-6.99%
More